Schott invests in glass expansion at its Swiss production plant

By on May 3, 2022 0

Schott plans to invest in an expansion of production at its glass manufacturing facility in St. Gallen, Switzerland.

The international technology group will increase the production capacity of its ready-to-use cartridges (RTU).

The expansion is designed to include cleanroom infrastructure, including washing line equipment supplied by machine supplier Groninger, and is expected to be completed in 2023.

The capacity expansion is designed to usher in a new era of manufacturing with a non-contact glass-to-glass process.

This is intended to remove any scratches or other defects in the glass and aids in the safe delivery of medications to patients.

Additionally, the new in-house steam sterilization will feature ultra-clean sterilization technology, paving the way for a more sustainable manufacturing process.

The production technology also includes an in-line seam inspection system, ensuring container closure integrity (CCI). This in turn means that the cartridge system effectively protects the sterility of the drug and therefore the stability of the drug.

Ready-to-use cartridges are used to store and administer medications using injection pens or portable devices.

Schott can supply these cartridges washed, siliconized, crimped and pre-sterilized in a nest/bin or tray configuration. This allows pharmaceutical companies to immediately start the drug filling process without having to deal with washing, siliconization or sterilization themselves.

With this expansion, the company will provide a solution for drugs that are primarily self-administered at home, which experts recognize as a growing market trend.

“This investment is another step in increasing manufacturing capacity for a product that simplifies self-medication and puts patient needs first,” said Andreas Reisse, executive vice president of Schott’s business unit. Pharmaceuticals.